Yuhai et al. found that NF-κB-sensitive miRNA-34a was upregulated in sporadic AD patients, consistently with downregulated TREM2 expression [129], suggesting the potential therapeutic role of miRNA-34a for regulating innate immune and phagocytic responses in neuroinflammation. Here, NFKB1 is linked to Alzheimer disease.